INR 18.18
(-2.73%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.06 Million | 109.58 Million | 206.97 Million | 17.55 Million | 94.94 Million | 100.72 Million |
Net Income | -25.83 Million | 3.17 Million | 30.05 Million | 374.04 Million | 248.77 Million | 433.05 Million |
Depreciation & Amortization | 13.96 Million | 15.8 Million | 12.41 Million | 13.63 Million | 17.11 Million | 22.02 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 8.73 Million | 86.61 Million | 152.51 Million | -18.35 Million | 63.78 Million | -270.71 Million |
Other non-cash items | -10.3 Million | 3.98 Million | 11.99 Million | -351.77 Million | -234.72 Million | -83.64 Million |
Investing Cash Flow | -3.92 Million | -12.81 Million | -13.48 Million | -6.93 Million | -1.97 Million | -9.86 Million |
Investments in PPE | -3.92 Million | -15.64 Million | -26.24 Million | -4.35 Million | -2.41 Million | -21.93 Million |
Acquisitions | - | 800 Thousand | 750 Thousand | 360 Thousand | 152 Thousand | 200 Thousand |
Investment purchases | - | - | -135.78 Thousand | -11.88 Million | -3.49 Million | 25.49 Million |
Sales/Maturities of investments | - | - | 9.94 Million | 948.64 Thousand | 2.82 Million | 60 Thousand |
Other Investing Activities | 2.94 Million | 2.02 Million | 2.19 Million | 8 Million | 959.91 Thousand | -13.67 Million |
Financing Cash Flow | 7.44 Million | -97.15 Million | -206.21 Million | -2.09 Million | -102.04 Million | -78.16 Million |
Debt repayment | -7.3 Million | -90.52 Million | -198.38 Million | -3.28 Million | -93.61 Million | -67.41 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 147 Thousand | - | - | - | - | - |
Other Financing Activities | 147 Thousand | -6.63 Million | -7.83 Million | 1.18 Million | -8.43 Million | -10.74 Million |
Accounts receivables | 32.85 Million | 123.09 Million | 146.56 Million | 21.71 Million | -37.24 Million | -354.88 Million |
Accounts payables | 36.21 Million | 12.1 Million | 54.43 Million | -37.34 Million | 8.78 Million | -12.03 Million |
Inventory | -29.76 Million | 44.84 Million | -53.5 Million | 5.34 Million | 37.37 Million | 80.86 Million |
Other working capital | -30.56 Million | -93.43 Million | 5.01 Million | -8.07 Million | 54.87 Million | 15.33 Million |
Cash at beginning of period | 998 Thousand | 1.38 Million | 14.1 Million | 5.57 Million | 14.64 Million | 1.95 Million |
Cash at end of period | 2.45 Million | 997 Thousand | 1.38 Million | 14.1 Million | 5.57 Million | 14.64 Million |
Capital Expenditure | -3.92 Million | -15.64 Million | -26.24 Million | -4.35 Million | -2.41 Million | -21.93 Million |
Effect of forex changes on cash | - | -1000.00 | 1000.00 | - | - | - |
Net cash flow / Change in cash | 1.45 Million | -386 Thousand | -12.72 Million | 8.52 Million | -9.07 Million | 12.69 Million |
Free Cash Flow | -5.99 Million | 93.94 Million | 180.72 Million | 13.2 Million | 92.52 Million | 78.79 Million |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -25.83 Million | -1.44 Million | -3.24 Million | -13.54 Million | 3.17 Million | 703 Thousand |
Depreciation & Amortization | 13.96 Million | 3.46 Million | 3.45 Million | 3.4 Million | 15.8 Million | 4.04 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 8.73 Million | - | - | - | 86.61 Million | - |
Other non-cash items | -10.3 Million | -3.46 Million | -3.45 Million | -3.4 Million | 3.98 Million | -4.04 Million |
Investing Cash Flow | -3.92 Million | - | - | - | -12.81 Million | - |
Investments in PPE | -3.92 Million | - | - | - | -15.64 Million | - |
Acquisitions | - | - | - | - | 800 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 2.02 Million | - |
Financing Cash Flow | 7.44 Million | - | - | - | -97.15 Million | - |
Debt repayment | -7.3 Million | - | - | - | -90.52 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 147 Thousand | - | - | - | - | - |
Other Financing Activities | 147 Thousand | - | - | - | -6.63 Million | - |
Accounts receivables | 32.85 Million | - | - | - | 123.09 Million | - |
Accounts payables | 36.21 Million | - | - | - | 12.1 Million | - |
Inventory | -29.76 Million | - | - | - | 44.84 Million | - |
Other working capital | -30.56 Million | - | - | - | -93.43 Million | - |
Cash at beginning of period | 998 Thousand | 6.52 Million | 9.77 Million | 998 Thousand | 1.38 Million | 295 Thousand |
Cash at end of period | 2.45 Million | -1.44 Million | 6.52 Million | -13.54 Million | 997 Thousand | 998 Thousand |
Capital Expenditure | -3.92 Million | - | - | - | -15.64 Million | - |
Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
Net cash flow / Change in cash | 1.45 Million | -7.97 Million | -3.24 Million | -14.54 Million | -386 Thousand | 703 Thousand |
Free Cash Flow | -5.99 Million | -1.44 Million | -3.24 Million | -13.54 Million | 93.94 Million | 703 Thousand |
3577
0L5V
0459
BIOTEC
SLM
YOGI